Teva Pharma Belgium

Company number 0451.951.110

Track this competitor Create a free account to be notified when it wins a contract.

Contracts won: 9
Amount won alone: €6,331,169 excl. VAT
Shared contracts: 4 (multi-supplier framework agreements)
Period: 29 April 2024 – 10 June 2026

Its main clients

CHIREC · 2 contracts
Universitair Ziekenhuis Gent · 1 contract
Vzw AZ Sint-Lucas & Volkskliniek · 1 contract
UZ Leuven · 1 contract
AZ Alma · 1 contract
Association iris-Achats · 1 contract
Vivalia · 1 contract
AZ Sint-Jan Brugge AV · 1 contract

Where and what

Supplies · 9

East Flanders · 3 Brussels-Capital · 3 Flemish Brabant · 1 West Flanders · 1

Its contracts coming to an end

So many opportunities to take over these contracts when they are re-tendered.

Planned end	Contract	Current holder	Amount
2 February 2027 re-tender around October 2026	Granulocyt koloniestimulerende factoren AZ Alma	Teva Pharma Belgium 2 bids received	€3,273,307
20 March 2027 re-tender around October 2026	Langwerkende en kortwerkende Filgrastim UZ Leuven framework agreement	sandoz ACCORD HEALTHCARE Teva Pharma Belgium AMGEN NV 4 bids received	€11,618,058
2 April 2027 re-tender around October 2026	Raamovereenkomst voor de levering van Ranibizumab Vzw AZ Sint-Lucas & Volkskliniek framework agreement	Teva Pharma Belgium 3 bids received	€990,662
22 October 2028 re-tender around April 2028	Facteurs de stimulation des colonies de granulocytes (G-CSF) CHIREC	Teva Pharma Belgium ACCORD HEALTHCARE 4 bids received	€277,997
31 December 2028 re-tender around July 2028	Spécialités pharmaceutiques à base de Ranibizumab Association iris-Achats	Teva Pharma Belgium 4 bids received	€1,496,000

Contracts won

Date	Contract	Buyer	Amount
10/06/2026	Raamovereenkomst voor het leveren van middelen in verband met de bloedvorming (neutropenie)	Universitair Ziekenhuis Gent	€3,197,922 shared by 3
05/06/2025	Raamovereenkomst voor de levering van Ranibizumab	Vzw AZ Sint-Lucas & Volkskliniek	€990,662
26/03/2025	Langwerkende en kortwerkende Filgrastim	UZ Leuven	€11,618,058 shared by 4
05/02/2025	Granulocyt koloniestimulerende factoren	AZ Alma	€3,273,307
17/01/2025	Ranibizumab	CHIREC	€571,200
09/01/2025	Spécialités pharmaceutiques à base de Ranibizumab	Association iris-Achats	€1,496,000
17/12/2024	Facteurs de stimulation des colonies de granulocytes (G-CSF)	CHIREC	€277,997 shared by 2
10/07/2024	Accord-cadre relatif à la fourniture de RANIBIZUMAB pour injection intravitréenne pour les besoins des pharmacies de Vivalia, agissant en Centrale d’achats	Vivalia	–
29/04/2024	Raamovereenkomst voor leveren van Cytostatica geneesmiddelen	AZ Sint-Jan Brugge AV	€3,379,003 shared by 10

Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.